The Max Delbrück Center for Molecular Medicine (Max Delbrück Center) is one of the world’s leading biomedical research institutions. Max Delbrück, a Berlin native, was a Nobel laureate and one of the founders of molecular biology. At the Max Delbrück Center’s locations in Berlin-Buch and Mitte, researchers from some 60 countries analyze the human system – investigating the biological foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts the dynamic equilibrium in a cell, an organ, or the entire body, we can prevent diseases, diagnose them earlier, and stop their progression with tailored therapies. Patients should benefit as soon as possible from basic research discoveries. The Max Delbrück Center therefore supports spin-off creation and participates in collaborative networks. It works in close partnership with Charité – Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and the German Center for Cardiovascular Research (DZHK). Founded in 1992, the Max Delbrück Center today employs 1,600 people and guests and is funded 90 percent by the German federal government and 10 percent by the State of Berlin.
The cells in our bodies are full of small, circular RNA molecules. Researchers have now discovered that these molecules impact the ways in which we think and learn.
Naked mole rats have been developing protective mechanisms against cancer, strokes and heart attacks for millions of years. Without oxygen, they can survive for up to 18 minutes. All of this makes…
After a stroke has occurred, every minute counts. The new ray of hope is a so-called micro-catheter, with which doctors manually remove the dangerous blood clots from the blocked vessel. But it will…
Looking for a treatment for hereditary Huntington's disease , a research team at the Berlin Max Delbrück Center demonstrates criminological serendipity.
Berlin-based scientist Ulrike Stein has discovered a gene that is responsible for the growth of tumours. Will this make cancer more predictable in the future?
Anne-Lise Børresen-Dale is a leading authority in the field of breast cancer research, mother of two adult daughters, and proud grandma. Soon she will come to Germany for an extended research visit.…
The survey due to start in the coming year will be on a grand scale, with 200,000 subjects set to take part in the biggest German long-term health research project to date. Interview with research…
The survey due to start in the coming year will be on a grand scale, with 200,000 subjects set to take part in the biggest German long-term health research project to date. Interview with research…
Across the globe, some 250 million people suffer from the medical condition of excess body fat. Researchers from the Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch, a member of the…
Contact
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft